Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers

  • Why depression and aging are linked to increased disease risk

  • Birth season affects your mood in later life, new research suggests

  • Highly Connected CEOs More Likely to Broker Mergers and Acquisitions That Harm Firms

  • Irritable bowel syndrome: Males report more social stress than females

  • New test to help brain injury victims recover

  • Panic attacks associated with fear of bright daylight

  • Fish intake associated with boost to antidepressant response

  • Aspirin shown to benefit schizophrenia treatment

  • American Alzheimer's plan milestones must be strengthened to meet goal by 2025, experts say

  •